Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul A. Mahon currently holds 36,781 shares of UNITED THERAPEUTICS Corp (UTHR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul A. Mahon has been a net seller of UTHR stock. They have purchased $0 and sold $226.1M worth of shares.
Paul A. Mahon's most recent insider trade was on Dec 24, 2025, when they sold 80 shares at $516.06 per share.
Paul A. Mahon serves as Executive at UNITED THERAPEUTICS Corp (UTHR). They have executed 1103 insider transactions totaling $226.1M over their tenure at the company.
Paul A. Mahon holds the position of Executive at UNITED THERAPEUTICS Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Paul A. Mahon has shown a selling trading pattern, with $0 in total purchases and $226.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul A. Mahon was on Dec 11, 2025, when they sold $2.5M worth of UTHR shares. This transaction involved 5,220 shares at $484.31 per share.
Paul A. Mahon currently owns 36,781 shares of UNITED THERAPEUTICS Corp (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul A. Mahon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul A. Mahon has 1103 Form 4 filings on record as an insider at UNITED THERAPEUTICS Corp.
Set alerts for Paul A. Mahon and 40,000+ other insiders.